Advances in Biomarkers: Going Beyond the Carcinoembryonic Antigen. Clin Colon Rectal Surg 2016 Sep;29(3):196-204
Date
09/02/2016Pubmed ID
27582644Pubmed Central ID
PMC4988861DOI
10.1055/s-0036-1584289Scopus ID
2-s2.0-84983044034 (requires institutional sign-in at Scopus site) 10 CitationsAbstract
Using biologically available markers to guide treatment decisions in colorectal cancer care is becoming increasingly common, though our understanding of these biomarkers is in its infancy. In this article, we will discuss how this area is rapidly changing, review important biomarkers being used currently, and explain how the results influence clinical decision-making. We will also briefly discuss the possibility of a liquid biopsy and explore several exciting and new options.